Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GJB2 | P29033 | 5/20 | 0.46 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.39 |
| ▸ | TNF | P01375 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.37 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.37 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.37 |
| ▸ | FGF1 | P05230 | 1/20 | 0.35 |
| ▸ | ENGASE | Q8NFI3 | 1/20 | 0.35 |
| ▸ | GBA1 | P04062 | 1/20 | 0.35 |
| ▸ | SELL | P14151 | 1/20 | 0.34 |
| ▸ | SELP | P16109 | 1/20 | 0.34 |
| ▸ | CD209 | Q9NNX6 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15883868 | 0.94 | GJB2 (0.48) | GJB2SLC2A1TNFFGF1GBA1 | |
| SCHEMBL10291406 | 0.94 | GJB2 (0.48) | GJB2SLC2A1TNFFGF1GBA1 | |
| SCHEMBL14854492 | 0.92 | GJB2 (0.44) | GJB2SLC2A1TNFMAPK1LGALS8 | |
| SCHEMBL10292101 | 0.91 | GJB2 (0.48) | GJB2TNFFGF1GBA1 | |
| SCHEMBL19204221 | 0.91 | GJB2 (0.48) | GJB2TNFFGF1GBA1 | |
| SCHEMBL18315050 | 0.88 | GJB2 (0.50) | GJB2TNFLGALS8LGALS3LGALS4 | |
| SCHEMBL10291407 | 0.88 | GJB2 (0.50) | GJB2TNFLGALS8LGALS3LGALS4 | |
| SCHEMBL14846437 | 0.87 | GJB2 (0.45) | GJB2TNFMAPK1LGALS8LGALS3 | |
| SCHEMBL13620137 | 0.86 | GJB2 (0.46) | GJB2TNFMAPK1LGALS8LGALS3 | |
| SCHEMBL19204198 | 0.85 | GJB2 (0.52) | GJB2TNFLGALS8LGALS3LGALS4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110046003-A1 | ALPHA-SELECTIVE SIALYL PHOSPHATE DONORS FOR PREPARATION OF SIALOSIDES AND SIALOSIDE ARRAYS FOR INFLUENZA VIRUS DETECTION | ACADEMIA SINICA (TW) | 2011-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110046003-A1 | ALPHA-SELECTIVE SIALYL PHOSPHATE DONORS FOR PREPARATION OF SIALOSIDES AND SIALOSIDE ARRAYS FOR INFLUENZA VIRUS DETECTION | NEU4, ST6GAL1, NEU3 | GJB2 1185/4885SLC2A1 1328/4885TNF 4795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.